Why EximRx / The problem
The data exists, but isn’t readily usable.
Across the markets where customs records are published, the detail that matters is buried in free-text product descriptions: products, quantities, values, origins, destinations and companies. In raw form, almost none of it can be analysed.
What goes wrong
One molecule, brand or company, a hundred ways.
Names do not match
The same molecule, brand or company shows up a hundred different ways. Subsidiaries look like unrelated companies.
Details go missing
Strengths go missing. Packaging notes end up in product names.
Units do not hold still
Units switch from grams to vials to cartons within a single dataset.
So teams compromise
Most teams either sink weeks into manual clean-up or accept insights that miss part of the market.
What EximRx doesA hundred spellings of one molecule, brand, supplier or buyer. EximRx resolves them to one.
EximRx differentiator
From a shipment log to a market database.
What you get is not a shipment log. It is a market database.
Without EximRx
A shipment log
- The same molecule, supplier or buyer appears a hundred different ways.
- Records that name only a brand stay unclassified.
- Customs records with missing product descriptions are ignored.
- Category-level (ATC) analysis is not feasible.
- A single molecule has to be searched many ways to get the full picture.
With EximRx
A market database
- One nameEach molecule, supplier and buyer is normalised to one name, wherever it is filed.
- Brands resolvedBrand-only records are tagged to a molecule through drug registries, where feasible.
- Gaps recoveredRecords with missing descriptions are recovered using port-level customs data, in select markets.
- Whole classesMolecules are mapped to ATC categories, so you can analyse a whole product class.
- Answers in secondsCustom dashboards for analysis in seconds.
- Coverage shownCoverage is highlighted against actual customs statistics, for transparency.